TUMOUR CAVITATION

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting TUMOUR CAVITATION:

# Drug Count
0 BEVACIZUMAB 6
1 PACLITAXEL 6
2 PEMBROLIZUMAB 4
3 RAMUCIRUMAB 4
4 REGORAFENIB 4
5 ATEZOLIZUMAB 3
6 CARBOPLATIN 3
7 NIVOLUMAB 3
8 DOCETAXEL 2
9 DOCETAXEL ANHYDROUS 2
See all common drugs associated with TUMOUR CAVITATION

TUMOUR CAVITATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NALDEMEDINE 1 0.0011
1 RAMUCIRUMAB 4 0.0010
2 REGORAFENIB 4 0.0005
3 ATEZOLIZUMAB 3 0.0002
4 AFATINIB 1 0.0002
5 LENVATINIB 2 0.0002
6 PEMBROLIZUMAB 4 0.0001
7 PACLITAXEL 6 0.0001
8 SUVOREXANT 1 0.0001
9 BEVACIZUMAB 6 0.0001
See all drugs enriched for association with TUMOUR CAVITATION